ECLBX | VMLTX | ECLBX / VMLTX | |
Total Expense Ratio | 1.40 | 0.17 | 824% |
Annual Report Gross Expense Ratio | 1.58 | 0.17 | 929% |
Fund Existence | 10 years | 38 years | - |
Gain YTD | 1.525 | 0.646 | 236% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 69.7M | 31B | 0% |
Annual Yield % from dividends | 2.07 | 2.92 | 71% |
Returns for 1 year | 3.20 | 1.21 | 265% |
Returns for 3 years | 6.66 | 1.85 | 361% |
Returns for 5 years | 2.02 | -2.17 | -93% |
Returns for 10 years | 9.05 | -0.33 | -2,760% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SPXX | 17.97 | 0.13 | +0.73% |
Nuveen S&P 500 Dynamic Overwrite Fund | |||
HCOW | 23.56 | 0.09 | +0.38% |
Amplify COWS Covered Call ETF | |||
RIGS | 23.15 | 0.01 | +0.06% |
RiverFront Strategic Income ETF | |||
THNR | 22.98 | N/A | -0.01% |
Amplify Weight Loss Drug & Treatment ETF | |||
BWX | 23.38 | -0.05 | -0.21% |
SPDR® Blmbg Intl Trs Bd ETF |